Natural Harmony Foods Inc (NHYF)

[solong]

A couple of reminders from the 3rd qtr report: https://www.otcmarkets.com/otcapi/company/financial-report/386610/content (just 1st couple of sentences of each item)

Page 5 - item C - NHYF has executed one Option agreement and two Memorandums of Understanding to evaluate investment in and/or the further development of the following AI-based medical technology:

• Life-Saving Innovation: AI-based intellectual property for the fast and early identification of life threatening pulmonary embolisms using CAT scan detection software.
• Facial Analysis to objectively screen for PTSD: AI-based facial analysis technology to objectively screen for posttraumatic stress disorder. The technology will analyze and interpret facial data, the result of which will be seen immediately by the user – with an option of sending it to their medical practitioner. (Estimated market for treating PTSD is $300 bn annually)
• Evolution in Evaluation and Treatment of Pain Management: A breakthrough new AI program (Chatbot) to simulate conversation with individuals suffering from chronic pain.

NHYF's vision extends beyond AI, encompassing innovative nutraceutical solutions. The company is poised to launch an anti-anxiety product - the first of its nutritional supplements that can be added to medical protocols for the long term management of anxiety.

7. Subsequent Events (last page of the filing)
In October 2023, the Company entered into a Securities Purchase and Subscription Agreement (SPA) with Global Corporate Finance Inc. (“GCF”), a private family office located in New York City, to provide working capital that will underpin the Company’s growth. The SPA will enable the Company to draw up to US$5,000,000 at its discretion over a period of 30 months